Kazakhstan vs Latin America & the Caribbean (IDA & IBRD countries): Immunization, Hib3
Immunization, Hib3 over time
- Kazakhstan
- Latin America & the Caribbean (IDA & IBRD countries)
How they compare
Kazakhstan currently reports 98.0% against 81.6% in Latin America & the Caribbean (IDA & IBRD countries), a difference of 16.4%.
That makes Kazakhstan's figure about 1.2 times Latin America & the Caribbean (IDA & IBRD countries)'s.
The two have swapped places 3 times across 17 shared years of data; in 2008 it was Latin America & the Caribbean (IDA & IBRD countries) ahead.
Kazakhstan ranks 20th and Latin America & the Caribbean (IDA & IBRD countries) ranks 23rd of 191 countries.
Across the 3 decades both report, Kazakhstan averaged higher in 2 and Latin America & the Caribbean (IDA & IBRD countries) in 1.
Head to head by decade
| Decade | Kazakhstan | Latin America & the Caribbean (IDA & IBRD countries) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 73.0% | 91.2% | 18.2% | Latin America & the Caribbean (IDA & IBRD countries) |
| 2010s | 95.6% | 87.9% | 7.7% | Kazakhstan |
| 2020s | 95.8% | 78.7% | 17.1% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Kazakhstan or Latin America & the Caribbean (IDA & IBRD countries)?
- Kazakhstan, at 98.0% against 81.6% in Latin America & the Caribbean (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hib3 between Kazakhstan and Latin America & the Caribbean (IDA & IBRD countries)?
- 16.4%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Latin America & the Caribbean (IDA & IBRD countries)?
- 17 years are reported by both, from 2008 to 2024.
- How do Kazakhstan and Latin America & the Caribbean (IDA & IBRD countries) rank globally for immunization, hib3?
- Kazakhstan ranks 20th and Latin America & the Caribbean (IDA & IBRD countries) ranks 23rd of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.